top of page

Drug Product

Small-Batch Aseptic Fill-Finish

Aseptic fill-finish for preclinical and Phase I/II/III clinical supply — 2,000 to 5,000 vials per batch.

Small-Batch by Design

Clinical-scale batches are our core business, not an exception.

01/

Most CDMOs are built for commercial volumes and treat a Phase I batch as a favor. We are built the other way round. A 2,000-vial campaign is a normal week here, not a scheduling problem — which means no commercial-scale minimums, no back-of-queue slotting, and no waiting for a gap between commercial runs.

2K–5K

vials per batch

20–50 L

batch volume

25–50

vials / min

24/7

shift operations

Photos of GMP facility at OmniParticles

What we offer

1

Batch size 2,000–5,000 vials (20–50 L)

Run 2,000–5,000 vial batches as standard campaigns, with no commercial-scale minimum order.

2

Filling speed 25–50 vials/min · 10 mL RTU vials (ISO 8362)

Fill volumes up to 10 mL. Schedule clinical-phase programs into a dedicated small-scale suite rather than queuing behind commercial production.

3

24/7 shift operations

Operate 24/7 shifts to absorb surge demand and compress delivery timelines.

4

Tech transfer (process fit assessment, batch record preparation)

Execute tech transfer with process fit assessed against your formulation before filling begins.

DP_filling_line_operator.jpg

Modalities Supported

Subject to a product-specific facility fit and risk assessment

Small molecules

Large molecules / Biologics

ATMPs / Cell & Gene Therapies

ADCs

RNA therapeutics

Oligonucleotides

Peptides

Monoclonal antibodies (mAbs)

Viral vectors

Radiopharmaceutical cold kits

Some cytotoxic

Outside this list?
Assessed, not declined

Planning a clinical batch?

Talk to us about your clinical-phase fill-finish program.

CONTACT US

TEL

+82 2-741-6110

E-mail

Head Office

2F, 20 Seongsui-ro 7-gil, Seongdong-gu, Seoul, Korea

DP Facility

3F, 20 Seongsui-ro 7-gil, Seongdong-gu, Seoul, Korea

DS Facility

4F, 20 Seongsui-ro 7-gil, Seongdong-gu, Seoul, Korea

© Copyright 2026 OmniParticles. All Rights Reserved. Site designer MH

  • LinkedIn
bottom of page